Drug Shortage Report for POTASSIUM ACETATE INJECTION USP
| Report ID | 265959 |
| Drug Identification Number | 02362597 |
| Brand name | POTASSIUM ACETATE INJECTION USP |
| Common or Proper name | POTASSIUM ACETATE INJECTION |
| Company Name | JUNO PHARMA CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | POTASSIUM ACETATE |
| Strength(s) | 39.2% |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 x 50mL vial / fiole |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-08-26 |
| Estimated end date | 2026-01-16 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2025-11-19 | French | Compare |
| v8 | 2025-11-19 | English | Compare |
| v7 | 2025-10-21 | French | Compare |
| v6 | 2025-10-21 | English | Compare |
| v5 | 2025-10-01 | French | Compare |
| v4 | 2025-10-01 | English | Compare |
| v3 | 2025-08-27 | English | Compare |
| v2 | 2025-08-26 | French | Compare |
| v1 | 2025-08-26 | English | Compare |
Showing 1 to 9 of 9